XLON
FORF
Market cap6mUSD
Dec 08, Last price
9.25GBP
Name
Myhealthchecked PLC
Chart & performance
P/E
—
P/S
1.33
EPS
—
Div yield, %
—
Shrs. gr., 5y
26.41%
Rev. gr., 5y
157.32%
Revenues
4m
-67.14%
Net income
-2m
L+1,023.27%
CFO
-2m
L
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
MyHealthChecked PLC specializes in the creation and distribution of at-home health and wellbeing diagnostic solutions across the United Kingdom. Its product line encompasses the production and supply of the MyLotus testing strip. Additionally, the company offers COVID-19 sample collection kits under its MyHealthChecked brand, alongside a variety of other DNA and RNA self-testing options. Established in 2008, the firm was initially known as Concepta PLC before rebranding to MyHealthChecked PLC in December 2020, with its headquarters located in Cardiff, UK.
Key people
Madeleine Elizabeth Kennedy
Chief Financial Officer, Director · since 2019
Group Finance Director, Executive Director, Company Secretary · since 2013
David John Darrock
Chief Operating Officer · since 2018
Peter Dines
Non-Executive Director · since 2018
Non-Executive Director · since 2016
Non-Executive Director · since 2019
IPO date
Jul 05, 2013
Employees
21
Domiciled in
GB
Incorporated in
GB
Headquarters & legal address
ST JAMES HOUSE
ST JAMES SQUARE
CHELTENHAM, GLS GL50 3PR
GB
ST JAMES SQUARE
CHELTENHAM, GLS GL50 3PR
GB
Previous name
MYHEALTHCHECKED PLC
Previous name
CONCEPTA PLC
Previous name
FRONTIER RESOURCES INTERNATIONAL PLC
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||